Project Objectives
The list below is representative of project objectives for INNOVALYST clients. This list is categorized by business sector. Click the business sector heading below or above at right to learn more about INNOVALYST’s impact on these clients.
-
•To define novel approaches to objectify and stratify patients suffering from a complex neurological disease. Create a rational program of work.
-
•To design experiments and performed in vitro pharmacodynamics modeling of dose and schedule for a combination of two anti-HIV compounds with different modes of action.
-
•To address pivotal data and analysis issues for an NDA in oncology.
-
•To identify and prioritize mid-term opportunities associated with the future of health care that account for existing and acquired capabilities following the acquisition of a diagnostic company.
-
•To develop a process for managing ideas to drive R&D innovation.
-
•To design and monitor a technology development roadmap for a novel diagnostics platform.
-
•To assist the diagnostic division in making a decision upon investing in multiplex biomarker systems.
-
•To design and implement a non-invasive, multi-modal animal imaging facility within the institute.
-
•To perform due diligence during an acquisition of various assets and the potential of these assets to generate revenue.
-
•To analyze strengths, weaknesses, opportunities, and threats (SWOT analysis) for a company entering the digital microscopy market and to evaluate the company’s development plan.
-
•To establish a new screening department based on a novel screening platform. Develop strategic partnerships for new capabilities
-
•To establish strategic partnerships and associated business models. Support development of scientific advisory board, and mentor key personnel.
-
•To develop and Implement a plan to capitalize on a new technology platform.
-
•To advise CEO and CSO on scientific and business strategy for a new ADME detection platform.
-
•To revolutionize personalized medicine and diagnostics in both developed and undeveloped nations through the commercialization of inventions from a world-class research institute.
-
•To establish a program for assisting professors with the externalization of their IP.
-
•To establish and implement a strategic approach to investments in step-change Drug Discovery and Development technologies.
-
•To improve TB disease management by monitoring TB drug resistance around the world, and identifying new TB drug resistant strains.
-
•To perform due diligence on investment candidates.
-
•To evaluate and prioritize funding proposals.